Danish researchers have developed a gene-editing approach which they say could become a treatment for fusion-driven cancers including subtypes of acute myeloid leukaemia (AML).
Researchers from Aarhus University, Denmark, used CRISPR/Cas9 to devel...
1 year ago
People immunocompromised through lymphoma benefit from increasing numbers of COVID-19 booster vaccines, according to a new study.
The PROSECO study involved about 500 patients with lymphoma recruited at nine hospitals in England in 2021 and 2022....
1 year ago
